1601.0000 3.70 (0.23%)
NSE Nov 04, 2025 15:31 PM
Volume: 43,178
 

1601.00
0.23%
Prabhudas Lilladhar
Strong FY26 guidance with +15% revenue growth with 36% OPM. up 70% YoY). Eris has opted for inorganic route to diversify and scale up expect margins to scale up from the current level of 35% as revenue scales up from recent acquisitions, which are currently operating at sub-optimal profitability. The company has multiple growth levers such as broad-based...
Eris Lifesciences Ltd. is trading below its 30 day SMA of 1604.1
More from Eris Lifesciences Ltd.
Recommended